Frederick, MD, United States of America

James Dennen O'Neil

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James Dennen O'Neil

Introduction

James Dennen O'Neil is a pioneering inventor based in Frederick, MD, whose work has resulted in five significant patents. He has focused his innovative efforts on developing compounds with therapeutic applications, especially in the area of reducing uric acid levels in mammalian subjects. His contributions hold promise for patients suffering from a variety of health conditions.

Latest Patents

O'Neil's latest patents include groundbreaking work on compounds and methods for reducing uric acid levels. His invention outlines a compound of Formula I, which is designed to lower uric acid and enhance its excretion. The patent details the structural composition of these compounds, including the variations in atoms and functional groups that make them effective in treating or preventing conditions such as gout, hyperuricemia, renal dysfunction, kidney stones, and cardiovascular disease. O'Neil has also developed tetrazole compounds that offer similar uric acid-lowering effects, providing a multifaceted approach to tackling elevated uric acid levels.

Career Highlights

James O'Neil is affiliated with Wellstat Therapeutics Corporation, where his inventive ideas find application and development. His career is characterized by a commitment to addressing pressing health issues through innovative pharmaceutical solutions. The work he has done with uric acid-lowering compounds showcases his dedication to improving the quality of life for those with metabolic disorders.

Collaborations

In his pursuit of innovation, O'Neil has collaborated with notable colleagues such as Shalini Sharma and Ramachandran Arudchandran. These partnerships in the pharmaceutical realm have fostered an environment of creativity and ambition, allowing them to pool their expertise for the advancement of healthcare solutions.

Conclusion

James Dennen O'Neil stands out as a leading figure in the field of pharmaceutical innovation, particularly in addressing uric acid-related health problems. His patents and collaborative efforts underscore the vital role of inventors in enhancing medical treatments. With each new development, O'Neil continues to contribute significantly to the landscape of scientific and medical advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…